IHAM
TMO icon

Integral Health Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Integral Health Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.83M Buy
+20,000
New +$10.9M 0.47% 57
2024
Q3 		– Sell
-25,000
Closed -$13.8M – 99
2024
Q2 		$13.8M Buy
+25,000
New +$14.3M 1.31% 24

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Integral Health Asset Management's TMO Position: Q1 2026 in Review

Integral Health Asset Management opened a new position in Thermo Fisher Scientific (TMO) in Q1 2026: 20,000 shares worth $9.83M. The stake represents 0.47% of the portfolio and ranks #57 among its holdings. This is a return to the name: Integral Health Asset Management previously reported a position in TMO as recently as Q2 2024.

Integral Health Asset Management first reported a position in TMO in Q2 2024 and has held it in 2 quarters since. The position peaked at $13.8M in Q2 2024. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Integral Health Asset Management held 20,000 shares of Thermo Fisher Scientific worth $9.83M as of Q1 2026.
  • Thermo Fisher Scientific was a new Integral Health Asset Management position in Q1 2026.
  • Thermo Fisher Scientific made up 0.47% of Integral Health Asset Management's portfolio in Q1 2026, its #57 holding.
  • Integral Health Asset Management first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 2 quarters since.
  • Integral Health Asset Management's Thermo Fisher Scientific position peaked at $13.8M in Q2 2024.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.